💊FDA Approval Update | #FDA recently approved #Yartemlea (#Narosoplimab-wuug) for #hematopoietic stem cell #transplant (#HSCT)-associated thrombotic microangiopathy
🔸Inhibits #lectin pathway effector enzyme — #MASP2
#HematopoieticStemCell #ThromboticMicroangiopathy